Literature DB >> 11078314

Major complications during spasm provocation tests with an intracoronary injection of acetylcholine.

S Sueda1, H Saeki, T Otani, K Mineoi, T Kondou, K Yano, T Ochi, N Ochi, Y Hayashi, T Tsuruoka, H Kawada, S Matsuda, T Uraoka.   

Abstract

This study sought to clarify major complications associated with acetylcholine testing. Serious major complications, such as sustained ventricular tachycardia, shock, and cardiac tamponade were determined in 4 of 715 patients (0.56%), but no cases of death or irreversible complications occurred. The spasm provocation test using acetylcholine should be performed carefully, although it is considered a safe and reliable method.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078314     DOI: 10.1016/s0002-9149(99)00754-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Complete definite positive spasm on acetylcholine spasm provocation tests: comparison of clinical positive spasm.

Authors:  Shozo Sueda; Toru Miyoshi; Yasuhiro Sasaki; Kousei Ohshima; Tomoki Sakaue; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2014-11-04       Impact factor: 2.037

2.  Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm.

Authors:  Shozo Sueda; Toru Miyoshi; Yasuhiro Sasaki; Tomoki Sakaue; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2014-11-01       Impact factor: 2.037

Review 3.  Provocative testing for coronary reactivity and spasm.

Authors:  Melody Zaya; Puja K Mehta; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2013-11-06       Impact factor: 24.094

Review 4.  Overview of the Acetylcholine Spasm Provocation Test.

Authors:  Shozo Sueda; Hiroaki Kohno; Takaaki Ochi; Tadao Uraoka
Journal:  Clin Cardiol       Date:  2015-07-14       Impact factor: 2.882

5.  Differential incidence and morphology of provoked spasm between intracoronary acetylcholine and ergonovine testing: recommendation of supplementary use.

Authors:  Shozo Sueda; Kaori Fujimoto; Yasuhiro Sasaki; Tomoki Sakaue; Toyofumi Yoshii; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2018-11-24       Impact factor: 2.037

6.  Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.

Authors:  Shozo Sueda; Toru Miyoshi; Ysuhiro Sasaki; Tomoki Sakaue; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2014-12-25       Impact factor: 2.037

7.  Impact of pharmacological spasm provocation test in patients with a history of syncope.

Authors:  Shozo Sueda; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2017-09-13       Impact factor: 2.037

8.  Maximal acetylcholine dose of 200 μg into the left coronary artery as a spasm provocation test: comparison with 100 μg of acetylcholine.

Authors:  Shozo Sueda; Hiroaki Kohno; Toru Miyoshi; Tomoki Sakaue; Yasuhiro Sasaki; Hirokazu Habara
Journal:  Heart Vessels       Date:  2014-09-02       Impact factor: 2.037

Review 9.  Stable angina pectoris.

Authors:  Marco Valgimigli; Simone Biscaglia
Journal:  Curr Atheroscler Rep       Date:  2014-07       Impact factor: 5.113

10.  Clinical characteristics in patients with rest angina and hypoplastic right coronary artery.

Authors:  Shozo Sueda; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2019-09-16       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.